Business Description
Biohit Oyj
ISIN : FI0009005482
Share Class Description:
OHEL:BIOBV: Class BCompare
Compare
Traded in other countries / regions
BIOBV.Finland0DRP.UK IPO Date
1999-06-18Description
Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry. Biohit's product portfolio consists of diagnostic tests, analysis systems, products that bind carcinogenic acetaldehyde into harmless compounds, monoclonal antibodies and service laboratory operations.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.14 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | 0.39 | |||||
| Interest Coverage | 4.78 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 8.93 | |||||
| Beneish M-Score | -1.16 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 22.2 | |||||
| 3-Year Book Growth Rate | 2.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 10.13 | |||||
| Future 3-5Y Total Revenue Growth Rate | 15.03 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.44 | |||||
| 9-Day RSI | 57.22 | |||||
| 14-Day RSI | 53.43 | |||||
| 6-1 Month Momentum % | 15 | |||||
| 12-1 Month Momentum % | 21.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | |||||
| Quick Ratio | 3.93 | |||||
| Cash Ratio | 1.67 | |||||
| Days Inventory | 58.53 | |||||
| Days Sales Outstanding | 115.41 | |||||
| Days Payable | 40.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.2 | |||||
| Shareholder Yield % | 0.29 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.99 | |||||
| Operating Margin % | 11.06 | |||||
| Net Margin % | 11.81 | |||||
| FCF Margin % | -3.91 | |||||
| ROE % | 16.95 | |||||
| ROA % | 12.5 | |||||
| ROIC % | 21.73 | |||||
| ROC (Joel Greenblatt) % | 40.65 | |||||
| ROCE % | 14.18 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 21.18 | |||||
| Forward PE Ratio | 14.56 | |||||
| PE Ratio without NRI | 21.18 | |||||
| Price-to-Owner-Earnings | 31.07 | |||||
| PS Ratio | 2.53 | |||||
| PB Ratio | 3.27 | |||||
| Price-to-Tangible-Book | 3.38 | |||||
| EV-to-EBIT | 21.5 | |||||
| EV-to-EBITDA | 17.19 | |||||
| EV-to-Revenue | 2.22 | |||||
| EV-to-FCF | -56.91 | |||||
| Price-to-Projected-FCF | 4.09 | |||||
| Price-to-Median-PS-Value | 0.52 | |||||
| Price-to-Graham-Number | 1.78 | |||||
| Price-to-Net-Current-Asset-Value | 3.7 | |||||
| Price-to-Net-Cash | 21.18 | |||||
| Earnings Yield (Greenblatt) % | 4.65 | |||||
| FCF Yield % | -1.54 | |||||
| Forward Rate of Return (Yacktman) % | 14.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biohit Oyj Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 13.976 | ||
| EPS (TTM) (€) | 0.11 | ||
| Beta | 0.39 | ||
| Volatility % | 22.59 | ||
| 14-Day RSI | 53.43 | ||
| 14-Day ATR (€) | 0.119084 | ||
| 20-Day SMA (€) | 2.2745 | ||
| 12-1 Month Momentum % | 21.05 | ||
| 52-Week Range (€) | 1.8 - 2.65 | ||
| Shares Outstanding (Mil) | 15.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biohit Oyj Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biohit Oyj Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biohit Oyj Frequently Asked Questions
What is Biohit Oyj(OHEL:BIOBV)'s stock price today?
The current price of OHEL:BIOBV is €2.33. The 52 week high of OHEL:BIOBV is €2.65 and 52 week low is €1.80.
When is next earnings date of Biohit Oyj(OHEL:BIOBV)?
The next earnings date of Biohit Oyj(OHEL:BIOBV) is 2025-02-14 Est..
Does Biohit Oyj(OHEL:BIOBV) pay dividends? If so, how much?
Biohit Oyj(OHEL:BIOBV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers